{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:04:41Z","timestamp":1782731081500,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013272","name":"Third Health Programme","doi-asserted-by":"publisher","award":["739543"],"award-info":[{"award-number":["739543"]}],"id":[{"id":"10.13039\/100013272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The development of new genetic testing methods and the approval of the first treatments raises questions regarding when and how to perform screening for inherited neuromuscular conditions. Screening directives and access to the different techniques is not uniform across Europe. The patient advisory board of the European reference network for rare neuromuscular diseases (NMD) conducted a qualitative study to understand the state of play of screening for inherited NMD in Europe and patients\u2019 needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We collected answers from 30 patient organisations (POs) from 18 European countries. Fifteen acknowledge the existence of pre-implantation genetic diagnosis in their country. Regarding prenatal screening, we had 25 positive answers and 5 negative ones. Twenty-four POs mentioned that newborn screening was available in their country. We had some contradictory answers from POs from the same country and in some cases; diseases said to be part of the screening programmes were not hereditary disorders. Twenty-eight organisations were in favour of screening tests. The reasons for the two negative answers were lack of reimbursement and treatment, religious beliefs and eventual insurance constrains. Most POs (21) were in favour of systematic screening with the option to opt-out. Regarding the timing for screening, \u201cat birth\u201d, was the most consensual response. The main priority to perform screening for NMDs was early access to treatment, followed by shorter time to diagnostic, preventive care and genetic counselling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to assess knowledge and needs of POs concerning screening for NMDs. The knowledge of POs regarding screening techniques is quite uneven. This implies that, even in communities highly motivated and knowledgeable of the conditions they advocate for, there is a need for better information. Differences in the responses to the questions \u201chow and when to screen\u201d shows that the screening path depends on the disease and the presence of a disease modifying treatment. The unmet need for screening inherited NMDs should follow an adaptive pathway related to the fast moving medical landscape of NMDs. International coordination leading to a common policy would certainly be a precious asset tending to harmonize the situation amongst European countries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01670-8","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:13:04Z","timestamp":1612930384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survey on patients\u2019 organisations\u2019 knowledge and position paper on screening for inherited neuromuscular diseases in Europe"],"prefix":"10.1186","volume":"16","author":[{"name":"ERN EURO-NMD Patient Advisory Board","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-9131","authenticated-orcid":false,"given":"Teresinha","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"3","key":"1670_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12687-011-0071-z","volume":"3","author":"SA Metcalfe","year":"2012","unstructured":"Metcalfe SA. Carrier screening in preconception consultation in primary care. J Community Genet. 2012;3(3):193\u2013203. https:\/\/doi.org\/10.1007\/s12687-011-0071-z.","journal-title":"J Community Genet"},{"issue":"3","key":"1670_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jpc.12632","volume":"51","author":"RM Lew","year":"2015","unstructured":"Lew RM, Burnett L, Proos AL, et al. Ashkenazi Jewish population screening for Tay\u2013Sachs disease: the international and Australian experience. J Paediatr Child Health. 2015;51(3):271\u20139. https:\/\/doi.org\/10.1111\/jpc.12632.","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"1670_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/gte.1998.2.271","volume":"2","author":"F Kaplan","year":"1998","unstructured":"Kaplan F. Tay\u2013Sachs disease carrier screening: a model for prevention of genetic disease. Genet Test. 1998;2(4):271\u201392. https:\/\/doi.org\/10.1089\/gte.1998.2.271.","journal-title":"Genet Test"},{"issue":"10","key":"1670_CR4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s10815-016-0768-3","volume":"33","author":"A Capalbo","year":"2016","unstructured":"Capalbo A, Romanelli V, Cimadomo D, Girardi L, Stoppa M, Dovere L, Dell\u2019Edera D, Ubaldi FM, Rienzi L. Implementing PGD\/PGD-A in IVF clinics: considerations for the best laboratory approach and management. J Assist Reprod Genet. 2016;33(10):1279\u201386. https:\/\/doi.org\/10.1007\/s10815-016-0768-3.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"1670_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.siny.2013.10.005","volume":"19","author":"N Babkina","year":"2014","unstructured":"Babkina N, Graham JM Jr. New genetic testing in prenatal diagnosis. Semin Fetal Neonatal Med. 2014;19(3):214\u20139. https:\/\/doi.org\/10.1016\/j.siny.2013.10.005 (Epub 2013 Dec 4).","journal-title":"Semin Fetal Neonatal Med"},{"key":"1670_CR6","doi-asserted-by":"publisher","DOI":"10.1530\/REP-19-0591","author":"J Shaw","year":"2020","unstructured":"Shaw J, Scotchman E, Chandler N, Chitty L. Non-invasive prenatal testing for aneuploidy, copy number variants and single gene disorders. Reproduction. 2020. https:\/\/doi.org\/10.1530\/REP-19-0591.","journal-title":"Reproduction"},{"key":"1670_CR7","first-page":"79","volume":"12","author":"S Elias","year":"1983","unstructured":"Elias S, Verp MS. Prenatal diagnosis of genetic disorders. Obstet Gynecol Annu. 1983;12:79\u2013102.","journal-title":"Obstet Gynecol Annu"},{"issue":"10","key":"1670_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrg.2016.97","volume":"17","author":"JR Vermeesch","year":"2016","unstructured":"Vermeesch JR, Voet T, Devriendt K. Prenatal and pre-implantation genetic diagnosis. Nat Rev Genet. 2016;17(10):643\u201356. https:\/\/doi.org\/10.1038\/nrg.2016.97.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"1670_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","volume":"39","author":"BL Therrell","year":"2015","unstructured":"Therrell BL, Padilla CD, Loeber JG, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39(3):171\u201387. https:\/\/doi.org\/10.1053\/j.semperi.2015.03.002.","journal-title":"Semin Perinatol"},{"key":"1670_CR10","unstructured":"\u201cPreimplantation Genetic Diagnosis in Europe\u201d. https:\/\/publications.jrc.ec.europa.eu\/repository\/bitstream\/JRC36703\/eur22764en.pdf. Accessed 03 Aug 2020."},{"key":"1670_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.34297\/AJBSR.2020.09.001353","volume":"9","author":"D Bogdan","year":"2020","unstructured":"Bogdan D, Simona C, Loredana N, Ovidiu-Dumitru I, Gabriela S, et al. First Romanian live birth after preimplantation genetic testing in a couple with severe oligospermia determined by Y chromosome microdeletions. Am J Biomed Sci Res. 2020;9:11. https:\/\/doi.org\/10.34297\/AJBSR.2020.09.001353.","journal-title":"Am J Biomed Sci Res"},{"key":"1670_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/sj.ejhg.5201976","volume":"16","author":"A Corveleyn","year":"2008","unstructured":"Corveleyn A, Morris M, Dequeker E, et al. Provision and quality assurance of pre-implantation genetic diagnosis in Europe. Eur J Hum Genet. 2008;16:290\u20139. https:\/\/doi.org\/10.1038\/sj.ejhg.5201976.","journal-title":"Eur J Hum Genet"},{"key":"1670_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.rbms.2017.01.001]","volume":"3","author":"MJ Bayefsky","year":"2016","unstructured":"Bayefsky MJ. Comparative pre-implantation genetic diagnosis policy in Europe and the USA and its implications for reproductive tourism. Reprod Biomed Soc Online. 2016;3:41\u20137. https:\/\/doi.org\/10.1016\/j.rbms.2017.01.001].","journal-title":"Reprod Biomed Soc Online"},{"key":"1670_CR14","unstructured":"Prenatal Screening Policies in Europe 2005. http:\/\/anr-dpn.vjf.cnrs.fr\/sites\/default\/files\/Eurocat_prenatal%20screening%20policies%20in%20Europe.pdf. Accessed 03 Aug 2020."},{"key":"1670_CR15","unstructured":"Prenatal Screening Policies in Europe 2010. https:\/\/www.orpha.net\/actor\/Orphanews\/2010\/doc\/Special-Report-Prenatal-Screening-Policies.pdf. Accessed 03 Aug 2020."},{"key":"1670_CR16","unstructured":"Report on the practices of newborn screening for rare disorders (RP-NBS) from 2016. http:\/\/www.isns-neoscreening.org\/wp-content\/uploads\/2016\/06\/Summary20111018.pdf. Accessed 03 Aug 2020."},{"key":"1670_CR17","unstructured":"Wilson JMG, Jungner G. The principles and practice of screening for World Health Organization, Geneva (1968), pp 26\u201339. https:\/\/apps.who.int\/iris\/handle\/10665\/208882.. Accessed 1968."},{"issue":"1","key":"1670_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","volume":"73","author":"MA Gatheridge","year":"2016","unstructured":"Gatheridge MA, Kwon JM, Mendell JM, et al. Identifying non-Duchenne muscular dystrophy-positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs: a review. JAMA Neurol. 2016;73(1):111\u20136. https:\/\/doi.org\/10.1001\/jamaneurol.2015.3537.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1670_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","volume":"41","author":"AB Burlina","year":"2018","unstructured":"Burlina AB, Polo G, Salviati L, et al. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North-East Italy. J Inherit Metab Dis. 2018;41(2):209\u201319. https:\/\/doi.org\/10.1007\/s10545-017-0098-3.","journal-title":"J Inherit Metab Dis"},{"key":"1670_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2017.08.012","volume":"77","author":"LF Ross","year":"2017","unstructured":"Ross LF, Clarke AJ. A historical and current review of newborn screening for neuromuscular disorders from around the world: lessons for the United States. Pediatr Neurol. 2017;77:12\u201322. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.08.012.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"1670_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.nmd.2019.02.003","volume":"29","author":"F Boemer","year":"2019","unstructured":"Boemer F, Caberg JH, Dideberg V, et al. Newborn screening for SMA in Southern Belgium. Neuromuscul Disord. 2019;29(5):343\u20139. https:\/\/doi.org\/10.1016\/j.nmd.2019.02.003.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1670_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JND-190428","volume":"6","author":"K Vill","year":"2019","unstructured":"Vill K, K\u00f6lbel H, Schwartz O, et al. One Year of newborn screening for SMA\u2014results of a German Pilot Project. J Neuromuscul Dis. 2019;6(4):503\u201315. https:\/\/doi.org\/10.3233\/JND-190428.","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"1670_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2471\/blt.07.050112","volume":"86","author":"A Andermann","year":"2008","unstructured":"Andermann A, Blancquaert I, Beauchamp S, D\u00e9ry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86(4):317\u20139. https:\/\/doi.org\/10.2471\/blt.07.050112.","journal-title":"Bull World Health Organ"},{"key":"1670_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14623","author":"P van Dommelen","year":"2020","unstructured":"van Dommelen P, van Dijk O, de Wilde JA, Verkerk PH. Early developmental milestones in Duchenne muscular dystrophy. Dev Med Child Neurol. 2020. https:\/\/doi.org\/10.1111\/dmcn.14623.","journal-title":"Dev Med Child Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01670-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01670-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01670-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:23:24Z","timestamp":1612931004000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01670-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1670"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01670-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-64046\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-64046\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}